Ulrich, Emma H.
Yordanova, Mariya
Morgan, Catherine
Benisty, Kelly
Riglea, Teodora
Huynh, Louis
Crépeau-Hubert, Frédérik
Hessey, Erin
McMahon, Kelly
Cockovski, Vedran
Wang, Stella
Zappitelli, Michael https://orcid.org/0000-0002-9977-0536
Article History
Received: 14 February 2024
Revised: 10 October 2024
Accepted: 23 October 2024
First Online: 25 November 2024
Declarations
: Dr. Zappitelli reported receiving personal fees from Bioporto Inc. for consulting work, and from Baxter Inc. for a talk on CRRT for sepsis and citrate anticoagulation. Dr. Zappitelli is Chair of the Data Safety Monitoring Board for an Eloxx Pharmaceuticals clinical trial. All involvement has no impact on the current manuscript. We declare that we do not have any conflicts of interest.